BIOMARKER TESTING RATES AMONG PATIENTS WITH ADVANCED NON-SQUAMOUS NON-SMALL CELL LUNG CANCER TREATED WITHIN LARGE COMMUNITY HEALTH SYSTEMS IN THE US

被引：0
|
作者：
Winzeler, A. [1 ]
Lorenzo, R. [1 ]
Pomerantz, D. [1 ]
Brown, T. [1 ]
Berry, A. [1 ]
机构：
[1] Syapse, San Francisco, CA USA
来源：
VALUE IN HEALTH | 2022年 / 25卷 / 07期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
RWD33
引用
收藏
页码：S582 / S582
页数：1
相关论文
共 50 条
  • [1] Molecular testing in older patients treated for an advanced or metastatic non-squamous non-small cell lung cancer
    Lamy, T.
    Cabarrou, B.
    Planchard, D.
    Quantin, X.
    Schneider, S.
    Bringuier, M.
    Besse, B.
    Perol, M.
    Girard, N.
    Schott, R.
    Chouaid, C.
    Ricordel, C.
    Gervais, R.
    Debieuvre, D.
    Audigier-Valette, C.
    Carton, M.
    Filleron, T.
    Simon, G.
    Robain, M.
    Baldini, C.
    [J]. ANNALS OF ONCOLOGY, 2021, 32 : S1243 - S1244
  • [2] Real-world biomarker testing rates and trends among patients with advanced non-small cell lung cancer in the US
    Chen, Yiyu
    Carlson, Angeline
    [J]. CANCER RESEARCH, 2024, 84 (06)
  • [3] Cemiplimab monotherapy in advanced non-squamous and squamous non-small cell lung cancer
    Rosell, Rafael
    Gonzalez-Cao, Maria
    [J]. LANCET, 2021, 397 (10274): : 557 - 559
  • [4] Nivolumab and brain metastases in patients with advanced non-squamous non-small cell lung cancer
    Crino, Lucio
    Bronte, Giuseppe
    Bidoli, Paolo
    Cravero, Paola
    Minenza, Elisa
    Cortesi, Enrico
    Garassino, Marina C.
    Proto, Claudia
    Cappuzzo, Federico
    Grossi, Francesco
    Tonini, Giuseppe
    Sarobba, Maria Giuseppina
    Pinotti, Graziella
    Numico, Gianmauro
    Samaritani, Riccardo
    Ciuffreda, Libero
    Frassoldati, Antonio
    Bregni, Marco
    Santo, Antonio
    Piantedosi, Francovito
    Illiano, Alfonso
    De Marinis, Filippo
    Tamberi, Stefano
    Giannarelli, Diana
    Delmonte, Angelo
    [J]. LUNG CANCER, 2019, 129 : 35 - 40
  • [5] THE EFFICACY AND TOXICITY OF CHEMOTHERAPY WITH BEVACIZUMAB FOR PREVIOUSLY TREATED PATIENTS WITH ADVANCED NON-SQUAMOUS NON-SMALL CELL LUNG CANCER
    Itotani, R.
    Kitajima, T.
    Inoue, D.
    Takamatsu, K.
    Ishitoko, M.
    Marumo, S.
    Sakuramoto, M.
    Fukui, M.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2014, 9 (04) : S47 - S47
  • [6] Safety and Efficacy of Apatinib in Patients with Previously Heavily Treated Advanced Non-Squamous Non-Small Cell Lung Cancer
    Wu, Feng Ying
    Zhang, Shi Jia
    Ren, Sheng Xiang
    Zhou, Caicun
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1286 - S1287
  • [7] A FEASIBILITY STUDY OF VINORELBINE AND BEVACIZUMAB IN PATIENTS WITH PREVIOUSLY TREATED ADVANCED NON-SQUAMOUS NON-SMALL CELL LUNG CANCER
    Kaburaki, Kyohei
    Isobe, Kazutoshi
    Yamamoto, Ai
    Tochigi, Naobumi
    Hata, Yoshinobu
    Shibuya, Kazutoshi
    Iyoda, Akira
    Homma, Sakae
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S887 - S887
  • [8] REAL-WORLD PATTERNS OF BIOMARKER TESTING IN METASTATIC NON-SQUAMOUS NON-SMALL CELL LUNG CANCER
    Roncadori, A.
    Massa, I
    Balzi, W.
    Danesi, V
    Rengucci, C.
    Gentili, N.
    Crino, L.
    Delmonte, A.
    Altini, M.
    [J]. VALUE IN HEALTH, 2022, 25 (01) : S255 - S255
  • [9] Atezolizumab in non-squamous non-small cell lung cancer
    Akamine, Takaki
    Toyokawa, Gouji
    Tagawa, Tetsuzo
    Seto, Takashi
    [J]. JOURNAL OF THORACIC DISEASE, 2018, 10 : S3155 - S3159
  • [10] Reflex Testing of EGFR and ALK in Non-Squamous Non-Small Cell Lung Cancer
    Tan, Jonan Z. -E.
    Ong, Whee-Sze
    Tan, Daniel S. -W.
    Takano, Angela
    Lim, Tony Kiat-Hon
    Chan, Kian-Sing
    Oon, Lynette Lin-Ean
    Lim, Alvin Soon-Tiong
    Jain, Amit
    Toh, Chee-Keong
    Ang, Mei-Kim
    Ng, Quan-Sing
    Kanesvaran, Ravindran
    Devanand, Anantham
    Lim, Chong-Hee
    Koh, Tina Puay-Theng
    Lim, Wan-Teck
    Tan, Eng Huat
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S698 - S699
12345